Chemotherapy-Induced Peripheral Neuropathy

Chemotherapy-induced peripheral neuropathy, commonly referred to as CIPN, is a frequent side effect resulting from the damage caused by certain cytotoxic drugs to the nerves outside the brain and spinal cord. While chemotherapy is a vital tool in the oncology arsenal, specific agents such as platinum compounds, taxanes, and vinca alkaloids can inadvertently injure the delicate peripheral nerve fibres. This damage typically manifests as sensory disturbances in the hands and feet, often described by patients as a 'gloves and stockings' distribution of symptoms. Understanding this condition is crucial for patients, as early identification can significantly influence the course of treatment and overall quality of life during and after cancer therapy.

Recognising the Symptoms of Nerve Damage

The clinical presentation of CIPN is primarily sensory, although motor and autonomic nerves can sometimes be involved. Patients usually report a gradual onset of tingling, often described as a 'pins and needles' sensation, or a numbness that makes performing fine motor tasks, like buttoning a shirt or picking up small objects, quite challenging. Some may experience a heightened sensitivity to touch or temperature, where even a light breeze or cool water feels painful. In more severe cases, a sharp, burning, or shooting pain may persist, which can interfere with sleep and daily activities. It is important to note that these symptoms might appear shortly after the first dose or emerge several months following the completion of the treatment cycle.

Mechanisms and Risk Factors

The biological basis of this neuropathy lies in the way chemotherapy agents affect the axons and myelin sheaths of the nerves. These drugs may disrupt the transport of nutrients within the nerve cell or cause oxidative stress that damages the nerve’s structural integrity. While the chemotherapy itself is the primary cause, certain pre-existing conditions can increase a patient's vulnerability to CIPN. These include:

• Pre-existing diabetes mellitus or chronic kidney disease.
• A history of heavy alcohol consumption.
• Nutritional deficiencies, particularly Vitamin B12.
• Previous exposure to other neurotoxic medications.

Understanding these risk factors allows the oncology team to tailor the treatment plan and monitor high-risk patients more closely for early signs of neurological changes.

The Importance of Clinical Assessment

Early detection remains the most effective strategy in managing CIPN. During your routine oncology visits, your physician will perform a focused neurological examination, testing your reflexes, strength, and sensitivity to vibration and light touch. Because there is currently no definitive diagnostic blood test for CIPN, your personal report of symptoms is the most valuable tool for the clinical team. We often use standardised questionnaires to track the severity of the symptoms over time. If the neuropathy is detected early, the oncologist may consider adjusting the chemotherapy dose, extending the interval between cycles, or switching to a different medication to prevent permanent nerve damage without compromising the primary cancer treatment goals.

Strategies for Managing Neuropathic Pain

Managing the discomfort associated with CIPN requires a multidisciplinary approach involving both pharmacological and non-pharmacological interventions. While traditional painkillers like paracetamol or ibuprofen are rarely effective for nerve-related pain, specific classes of medications such as anticonvulsants and certain antidepressants have been found to modulate the way the nervous system processes pain signals. These are not prescribed for epilepsy or depression in this context, but rather for their proven ability to calm hyper-excited nerves. Topical treatments, including lidocaine patches or compounded creams, may also provide localised relief for patients experiencing significant skin sensitivity or burning sensations in their extremities.

Supportive Care and Safety Measures

Beyond medication, lifestyle adjustments play a vital role in maintaining safety and comfort. Because neuropathy can affect balance and the ability to feel the ground, patients are at a higher risk of falls. Simple home modifications can significantly enhance safety:

• Removing loose rugs and clearing cluttered walkways.
• Using non-slip mats in the bathroom and installing grab bars.
• Wearing well-fitted, closed-toe shoes even when indoors.
• Regularly inspecting the feet for injuries or blisters that may not be felt.

Maintaining adequate hydration and a balanced diet rich in B-complex vitamins also supports nerve health. Some patients find relief through gentle physical therapy, which helps improve balance and strengthens the muscles affected by motor neuropathy.

The Role of the Pain and Palliative Specialist

If you find that the sensations of numbness, tingling, or pain are worsening, or if they are beginning to limit your ability to perform daily tasks and enjoy life, it is essential to request a consultation with a pain and palliative medicine specialist. We work closely with your primary oncologist to provide a layer of support focused entirely on symptom control and functional improvement. While the nerves often heal slowly over many months after chemotherapy concludes, professional intervention can provide the necessary relief to ensure you complete your oncological treatment with the highest possible level of comfort and dignity. Early referral is always preferable to waiting until the pain becomes difficult to manage.